• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to secondary sidebar

OINDPnews


Copley Scientific banner
  • Home
  • News
    • Business
    • Features
    • Medical
    • Regulatory
    • Products and Services
    • People
  • Events
  • Suppliers
    • Supplier listing and advertising options
    • Capsules and blisters
    • Consultants
    • Contract research
    • Contract manufacturing
    • Devices
    • Education
    • Excipients
      • Clinical Technology
    • Filling equipment
    • Instruments
    • Particle manufacturing
    • Software and modeling
  • Jobs
  • Resources
    • Webinars
    • White papers
  • LGWP Propellants
    • HFA 152a
    • HFO-1234ze(E)
    • LGWP Regulation
  • Contact

Chris Blackwell to step down as Vectura Chief Executive

Vectura Chief Executive Chris Blackwell will step down from that position at the end of June 2015, the company has announced. Blackwell has been with the company since 2002. The company’s board says that it plans a search for a new chief executive.

Vectura licenses its DPI devices and formulations to numerous pharmaceutical companies, most recently announcing a partnership with Janssen Biotech on development of DPIs for asthma and COPD.

Blackwell commented, “I am intensely proud of what we have achieved over the past twelve years and I feel that now is the right time to move on. I remain totally focused on the continued evolution of Vectura and I am confident that the business is in great shape, with the right senior management team to ensure that the company continues to thrive. I would also like to take this opportunity to express my gratitude to those, past and present, who have helped build the company, to those who have supported its growth and to the Board for their understanding and support.”

Vectura Board Chairman Bruno Angelici said, “I have enjoyed working with Chris and I warmly thank him for the great results achieved under his leadership. Whilst we will be sad to see Chris depart, he will leave the business in a very strong position. On behalf of the entire Board I would like to wish him well in his future endeavors.”

Read the Vectura press release.

Share

published on February 3, 2015

Primary Sidebar

Sign up for our free weekly newsletter

Upcoming Events
Sponsored by Intertek

Want information about upcoming OINDP-related events delivered directly to your inbox? click here

  • June 17-June 18: Rescon Europe 2025, Paris, France
  • June 19-June 20: Metered Dose Inhaler (MDI) Technology Training Course, online
  • June 22-June 25: ISAM Congress 2025, Washington, DC, USA
  • June 25-June 25: SMI.London 2025, London, UK
  • September 18-September 19: IPAC-RS Nasal Innovation Forum, West Trenton, NJ, USA
  • See all upcoming events

    Secondary Sidebar

    Suppliers

    Capsules and blisters
    Consultants
    Contract research
    Contract manufacturing
    Devices
    Education
    Excipients
    Filling equipment
    Instruments
    Particle manufacturing
    Software and modeling
    Aptar Pharma banner
    © 2025 OINDPnews